Zur Rose Group AG
A European e-commerce pharmacy providing an online platform for medicines and health.
ROSE | SW
Overview
Corporate Details
- ISIN(s):
- CH0042615283 (+1 more)
- LEI:
- 50670038OH136R5Z4663
- Country:
- Switzerland
- Address:
- Walzmühlestrasse 49, 8500 Frauenfeld
- Sector:
- Wholesale and retail trade
Description
DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-02 02:00 |
Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024 in…
|
English | 5.9 KB | ||
| 2024-05-02 02:00 |
Beschlüsse der 31. ordentlichen Generalversammlung der DocMorris AG vom 2. Mai…
|
German | 6.1 KB | ||
| 2024-04-30 07:00 |
Final allocation of DocMorris CHF 200 million Convertible Bonds Offering
|
English | 3.6 KB | ||
| 2024-04-30 02:00 |
Final allocation of DocMorris CHF 200 million Convertible Bonds Offering
|
English | 2.2 KB | ||
| 2024-04-30 02:00 |
Endgültige Zuteilung der DocMorris CHF 200 Mio. Wandelanleihe
|
German | 2.3 KB | ||
| 2024-04-18 07:00 |
DocMorris successfully completes the placement of CHF 200 million Convertible B…
|
English | 3.7 KB | ||
| 2024-04-18 02:00 |
DocMorris successfully completes the placement of CHF 200 million Convertible B…
|
English | 2.3 KB | ||
| 2024-04-18 02:00 |
DocMorris schliesst Platzierung einer CHF 200 Mio. Wandelanleihe mit Fälligkeit…
|
German | 2.3 KB | ||
| 2024-04-17 17:46 |
DocMorris launches approx. CHF 200 million Convertible Bonds due 2029
|
English | 3.7 KB | ||
| 2024-04-17 02:00 |
DocMorris launches approx. CHF 200 million Convertible Bonds due 2029
|
English | 2.3 KB | ||
| 2024-04-17 02:00 |
DocMorris lanciert Platzierung einer Wandelanleihe mit Gesamtnennwert von etwa …
|
German | 2.3 KB | ||
| 2024-04-16 06:57 |
DocMorris continues to grow in the first quarter of 2024 and creates digital ac…
|
English | 18.1 KB | ||
| 2024-04-16 02:00 |
DocMorris continues to grow in the first quarter of 2024 and creates digital ac…
|
English | 15.0 KB | ||
| 2024-04-16 02:00 |
DocMorris setzt Wachstumskurs im ersten Quartal 2024 fort und schafft digitalen…
|
German | 15.9 KB | ||
| 2024-04-10 07:00 |
DocMorris AG: DocMorris receives gematik approval for simple digital e-prescrip…
|
English | 10.7 KB |
Automate Your Workflow. Get a real-time feed of all Zur Rose Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zur Rose Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zur Rose Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 175,188.00 CHF |
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 28,818.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 34,500.00 CHF |
| 2025-05-19 | N/A | Non-Executive member | Buy | None | 14,040.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 9,142.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 1,035,000.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 46,400.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 10,315.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 8,616.00 CHF |
| 2025-05-15 | N/A | Executive member | Buy | None | 678,770.25 CHF |
Peer Companies
